Association of Male Sex and Microvascular Alterations on Optical Coherence Tomography Angiography in Diabetes.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 29 11 2023
pubmed: 27 11 2023
entrez: 27 11 2023
Statut: ppublish

Résumé

Epidemiologically, men have a higher incidence, severity, and progression of diabetic retinopathy (DR) than women. We investigated microvascular differences between men and women with diabetes on optical coherence tomography angiography (OCTA). Three × 3 mm OCTA macula scans of non-diabetic and patients with diabetes were obtained. Vascular parameters included parafoveal vessel density (VD), vessel length density (VLD), and flow index (FI) of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) as well as foveal avascular zone (FAZ) area and perimeter. Multivariable linear regression was used for statistical analysis. There were 1809 patients with diabetes and 217 non-diabetic participants that were included in this study. Diabetic individuals included those with no DR (n = 1356), mild non-proliferative DR (NPDR; n = 286), moderate NPDR (n = 126), and severe NPDR/proliferative DR (PDR; n = 41). Male sex was significantly associated with smaller FAZ area/perimeter and lower DCP VLD in both non-diabetic subjects and patients with diabetes. Male sex in the diabetic group was additionally associated with lower SCP VD/VLD and DCP VD. Addition of an interaction between male sex and diabetes status in the interaction analysis showed that being male and diabetic conferred increased reduction in DCP VD and VLD compared to sex-based changes in non-diabetics. Larger FAZ perimeter, lower SCP VD/VLD, and lower DCP VLD were associated with poorer visual acuity in diabetics. On OCTA, male patients with diabetes may have more severe microvascular disease especially in the DCP compared to women. Sex-based alterations in diabetic microvascular disease has the potential to influence future basic and clinical studies as well as the implementation of OCTA disease markers.

Identifiants

pubmed: 38010281
pii: 2793048
doi: 10.1167/tvst.12.11.30
pmc: PMC10683768
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

30

Références

Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Exp Eye Res. 2019 Dec;189:107856
pubmed: 31654619
Prog Retin Eye Res. 2017 May;58:115-151
pubmed: 28109737
J Clin Med. 2023 Mar 02;12(5):
pubmed: 36902761
Retina. 2019 Feb;39(2):247-258
pubmed: 30550527
Sci Rep. 2017 Feb 10;7:42201
pubmed: 28186181
Eye (Lond). 2021 May;35(5):1317-1325
pubmed: 32581390
Curr Eye Res. 2015 Feb;40(2):213-25
pubmed: 25153829
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2668-72
pubmed: 18515595
Stroke. 2002 Jun;33(6):1685-91
pubmed: 12053012
Int J Mol Sci. 2018 Mar 22;19(4):
pubmed: 29565290
JAMA Ophthalmol. 2018 Jul 1;136(7):721-728
pubmed: 29800967
Sci Rep. 2022 Jun 13;12(1):9780
pubmed: 35697817
Eur J Ophthalmol. 2022 Sep;32(5):2824-2832
pubmed: 35001682
J Clin Invest. 2015 Jun;125(6):2335-46
pubmed: 25915585
Int J Mol Sci. 2018 Mar 15;19(3):
pubmed: 29543707
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1321-1327
pubmed: 30933259
Acta Ophthalmol. 2017 Dec;95(8):e751-e755
pubmed: 28211261
PLoS One. 2020 Mar 20;15(3):e0230260
pubmed: 32196538
Sci Rep. 2016 Feb 25;6:22017
pubmed: 26912261
Ophthalmology. 2016 Nov;123(11):2352-2367
pubmed: 27523615
Opt Lett. 2010 May 1;35(9):1467-9
pubmed: 20436605
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO307-BIO315
pubmed: 29059262
Eye (Lond). 2020 Nov;34(11):2148-2149
pubmed: 32020059
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4830-4837
pubmed: 31747685
Microsc Res Tech. 2010 Oct;73(11):1019-29
pubmed: 20232465
Ophthalmol Retina. 2020 Apr;4(4):425-432
pubmed: 31926950
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT224-34
pubmed: 27409476
Transl Vis Sci Technol. 2021 Mar 1;10(3):12
pubmed: 34003946
Retina. 2015 Nov;35(11):2364-70
pubmed: 26469537
Biomed Opt Express. 2016 Jun 20;7(7):2709-28
pubmed: 27446700
Ophthalmology. 2019 Dec;126(12):1675-1684
pubmed: 31358386
Lancet Neurol. 2008 Oct;7(10):915-26
pubmed: 18722812
Diabetologia. 2003 May;46(5):608-17
pubmed: 12750769
Clin Ophthalmol. 2020 Apr 23;14:1107-1115
pubmed: 32425497
Am J Ophthalmol. 1982 Jun;93(6):745-56
pubmed: 6178293
J Geriatr Cardiol. 2016 Feb;13(2):183-96
pubmed: 27168746
Eur Heart J. 2008 Apr;29(7):932-40
pubmed: 18334475
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):190-196
pubmed: 28114579
Diabetologia. 2001 Feb;44(2):156-63
pubmed: 11270671
BMC Ophthalmol. 2021 Feb 12;21(1):82
pubmed: 33579225
Acta Diabetol. 2020 Jun;57(6):725-732
pubmed: 32025877
Sci Rep. 2019 Jun 20;9(1):8875
pubmed: 31221998
Lancet Neurol. 2012 Jan;11(1):82-91
pubmed: 22172623
Curr Eye Res. 2015 Feb;40(2):201-12
pubmed: 24892919
Vision Res. 2017 Oct;139:7-14
pubmed: 28412095
Eye Vis (Lond). 2022 Oct 1;9(1):38
pubmed: 36180939
Transl Vis Sci Technol. 2017 Jun 09;6(3):16
pubmed: 28616362
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
JAMA Ophthalmol. 2017 Apr 1;135(4):370-376
pubmed: 28301651
Am J Ophthalmol. 2016 Aug;168:95-109
pubmed: 27183862
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):53
pubmed: 32866267
PLoS One. 2018 Oct 18;13(10):e0205773
pubmed: 30335815

Auteurs

Yi Stephanie Zhang (YS)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Zuckerberg San Francisco General Hospital and Trauma Center, Department of Ophthalmology, San Francisco, CA, USA.

Abu T Taha (AT)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Zuckerberg San Francisco General Hospital and Trauma Center, Department of Ophthalmology, San Francisco, CA, USA.

Isabel J B Thompson (IJB)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.

Jeremy D Keenan (JD)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.

Daphne Yang (D)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Zuckerberg San Francisco General Hospital and Trauma Center, Department of Ophthalmology, San Francisco, CA, USA.

Joshua Wu (J)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Zuckerberg San Francisco General Hospital and Trauma Center, Department of Ophthalmology, San Francisco, CA, USA.

Jay M Stewart (JM)

University of California - San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Zuckerberg San Francisco General Hospital and Trauma Center, Department of Ophthalmology, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH